Revolution Medicines (RVMD) Current Leases (2020 - 2026)
Revolution Medicines' quarterly Current Leases came in at $16.6 million in Q1 2026, up 27.98% year-on-year from $13.0 million in Q1 2025, and up 0.86% quarter-over-quarter from $16.5 million in Q4 2025.
Revolution Medicines has reported Current Leases for 7 years, with the latest figure at $16.6 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 27.98% year-over-year to $16.6 million; the trailing twelve-month figure through Mar 2026 stood at $16.6 million (up 27.98% YoY), and the FY2025 full-year result was $16.5 million, up 27.94% from the prior year.
- Current Leases for Q1 2026 stood at $16.6 million, up from $16.5 million in the prior quarter.
- The five-year high for Current Leases was $16.6 million in Q1 2026, with the low at $5.7 million in Q2 2023.
- Average Current Leases over 5 years is $9.7 million, with a median of $8.2 million recorded in 2024.
- Year-over-year, Current Leases decreased 17.98% in 2023 and surged 94.45% in 2025.
- Tracing RVMD's Current Leases over 5 years: stood at $6.8 million in 2022, then increased by 8.8% to $7.4 million in 2023, then surged by 74.68% to $12.9 million in 2024, then increased by 27.94% to $16.5 million in 2025, then grew by 0.86% to $16.6 million in 2026.
- The last three Current Leases figures came in at $16.6 million (Q1 2026), $16.5 million (Q4 2025), and $16.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 16.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.61 Mn |
| Dec 31, 2025 | 16.47 Mn |
| Sep 30, 2025 | 16.33 Mn |
| Jun 30, 2025 | 13.09 Mn |
| Mar 31, 2025 | 12.98 Mn |
| Dec 31, 2024 | 12.87 Mn |
| Sep 30, 2024 | 8.40 Mn |
| Jun 30, 2024 | 8.33 Mn |
| Mar 31, 2024 | 8.17 Mn |
| Dec 31, 2023 | 7.37 Mn |
| Sep 30, 2023 | 5.76 Mn |
| Jun 30, 2023 | 5.72 Mn |
| Mar 31, 2023 | 5.92 Mn |
| Dec 31, 2022 | 6.77 Mn |
| Sep 30, 2022 | 7.02 Mn |
| Jun 30, 2022 | 6.03 Mn |
| Mar 31, 2022 | 6.33 Mn |
| Dec 31, 2021 | 6.21 Mn |
| Sep 30, 2021 | 4.96 Mn |
| Jun 30, 2021 | 4.93 Mn |
| Mar 31, 2021 | 3.70 Mn |
| Dec 31, 2020 | 3.67 Mn |
| Sep 30, 2020 | 3.65 Mn |
| Jun 30, 2020 | 3.62 Mn |
| Mar 31, 2020 | 3.29 Mn |